バイオ医薬品における人工知能（AI）の世界市場レポート 2025年

バイオ医薬品における人工知能（AI）の市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR33.2％で66億7,000万米ドルに成長します。予測期間の成長は、計算生物学の進歩、マルチモーダルデータの統合、AIとライフサイエンスの融合、規制支援とフレームワーク、倫理的で公正なAIの原則に起因します。予測期間の主な動向には、マルチオミクスデータの統合、AI主導の薬剤設計と発見、説明可能なAIと規制の受け入れ、技術の進歩、規制の進展、新たな機会などが含まれます。

慢性疾患の有病率の増加が、今後のバイオ医薬品における人工知能（AI）市場の成長を牽引すると予測されます。慢性疾患は、一般的にゆっくりと進行し、何年も、あるいは一生続く可能性のある長期的な疾患です。これらの疾患の要因には、ライフスタイルの選択、高齢化、遺伝的素因、環境の影響などがあります。AIは膨大な量の多様なデータを分析し、パターンを特定し、治療戦略をパーソナライズすることができるため、バイオ医薬品において慢性疾患の管理にますます活用されるようになっています。例えば、2023年11月、米国政府機関である保健福祉省は、2022年に新たに記録されたB型慢性肝炎患者は2021年に比べて11％増加したと報告しました。その結果、慢性疾患の有病率の上昇がAIバイオ医薬品市場の成長を促進しています。

バイオ医薬品における人工知能（AI）の主なプレーヤーは、創薬を迅速化し、精密医療を可能にするために、ターゲットやリードの同定スイートAI搭載ソリューションなどの革新的な進歩の開発に注力しており、それによってライフサイエンス組織を変革しています。創薬と精密医療のためのこれらのソリューションは、新薬の開発と個々の患者に合わせた治療のための様々な革新的アプローチを包含しています。例えば、米国を拠点とするクラウド・コンピューティング・サービスのプロバイダーであるグーグルLLCは、2023年5月、ターゲットおよびリード同定スイートと名付けられた2つの新しいAI搭載ツールを発表しました。これらのツールは、研究者が医薬品開発の基本であるタンパク質の構造を予測・理解するのを支援するように設計されています。さらに、精密医療への取り組みに不可欠な大量のゲノムデータの取り込み、保存、分析、共有を容易にします。さらに、これらのツールは創薬プロセスを合理化し、コストを削減し、新しい治療法の市場導入を促進します。効率的なデータ管理、タンパク質構造の正確な予測、高度なゲノム解析機能を提供することで、これらのツールは医薬品開発プロセスに革命をもたらし、患者の転帰を向上させることを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオ医薬品における人工知能（AI） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のバイオ医薬品における人工知能（AI）市場：成長率分析
• 世界のバイオ医薬品における人工知能（AI）市場の実績：規模と成長, 2019-2024
• 世界のバイオ医薬品における人工知能（AI）市場の予測：規模と成長, 2024-2029, 2034F
• 世界のバイオ医薬品における人工知能（AI）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオ医薬品における人工知能（AI）市場：提供別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハードウェア
• ソフトウェア
• サービス
• 世界のバイオ医薬品における人工知能（AI）市場：展開別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クラウド
• オンプレミス
• 世界のバイオ医薬品における人工知能（AI）市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機械学習
• 自然言語処理
• ディープラーニング
• その他の技術
• 世界のバイオ医薬品における人工知能（AI）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビジネスプロセスとサプライチェーン
• 創薬
• 医療画像診断
• 精密医療
• 世界のバイオ医薬品における人工知能（AI）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メーカー
• 契約調査機関
• 学術機関および政府調査機関
• 世界のバイオ医薬品における人工知能（AI）市場、タイプ別サブセグメンテーション：ハードウェア、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高性能コンピューティングシステム
• AI対応の実験装置
• データストレージソリューション
• 世界のバイオ医薬品における人工知能（AI）市場、タイプ別サブセグメンテーション：ソフトウェア、実績と予測, 2019-2024, 2024-2029F, 2034F
• 創薬プラットフォーム
• 臨床試験管理ソフトウェア
• 予測分析ツール
• 自然言語処理ソリューション
• 世界のバイオ医薬品における人工知能（AI）市場、タイプ別サブセグメンテーション：サービス、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 実装および統合サービス
• データ管理および分析サービス
• トレーニングおよびサポートサービス

第7章 地域別・国別分析

• 世界のバイオ医薬品における人工知能（AI）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオ医薬品における人工知能（AI）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオ医薬品における人工知能（AI）市場：競合情勢
• バイオ医薬品における人工知能（AI）市場：企業プロファイル
  • Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Tencent Holdings Limited Overview, Products and Services, Strategy and Financial Analysis
  • Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• International Business Machines Corporation
• Exscientia Limited
• NVIDIA Corporation
• Amgen Inc.
• DeepMind Technologies Limited
• Schrodinger Inc.
• XtalPi Inc.
• ConcertAI Inc.
• Insilico Medicine Inc.
• Recursion Pharmaceuticals
• BenevolentAI
• BioXcel Therapeutics
• Atomwise Inc.
• BioAge Labs Inc.
• GNS Healthcare

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオ医薬品における人工知能（AI）市場2029：新たな機会を提供する国
• バイオ医薬品における人工知能（AI）市場2029：新たな機会を提供するセグメント
• バイオ医薬品における人工知能（AI）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Artificial intelligence (AI) applied in the biopharmaceutical sector involves the utilization of diverse AI techniques to analyze intricate biological data and enhance different aspects of drug discovery, development, and delivery within the pharmaceutical domain. This application of AI holds significant potential for transforming drug discovery, development, and delivery processes by expediting timelines, cutting costs, and enhancing the efficiency and efficacy of treatments.

The primary categories of offerings in artificial intelligence (AI) within the biopharmaceutical sector encompass hardware, software, and services. Hardware pertains to the tangible components of a computer system, including devices such as memory, disk drives, controllers, and specialized software such as database management systems. These offerings span various deployment models, encompassing both cloud-based and on-premises solutions. The technologies employed include machine learning, natural language processing, and deep learning, with applications spanning business processes, supply chains, drug discovery, medical imaging and diagnostics, and precision medicine. The end users of these AI solutions are diverse, ranging from manufacturers and contract research organizations to academic and government research institutes.

The artificial intelligence (AI) in biopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in biopharmaceuticals market statistics, including artificial intelligence (AI) in biopharmaceuticals industry global market size, regional shares, competitors with an artificial intelligence (AI) in biopharmaceuticals market share, detailed artificial intelligence (AI) in biopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in biopharmaceuticals industry. This artificial intelligence (AI) in biopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in biopharmaceuticals market size has grown exponentially in recent years. It will grow from $1.59 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 33.1%. The growth in the historic period can be attributed to advancements in computational power, biomedical data explosion, precision medicine paradigm, regulatory support and guidance.

The artificial intelligence (AI) in biopharmaceuticals market size is expected to see exponential growth in the next few years. It will grow to $6.67 billion in 2029 at a compound annual growth rate (CAGR) of 33.2%. The growth in the forecast period can be attributed to advancements in computational biology, integration of multi-modal data, convergence of ai and life sciences, regulatory support and frameworks, ethical and fair ai principles. Major trends in the forecast period include integration of multi-omics data, AI-driven drug design and discovery, explainable AI and regulatory acceptance, technological advancements, regulatory developments, and emerging opportunities.

The increasing prevalence of chronic diseases is projected to drive the growth of the artificial intelligence (AI) in biopharmaceuticals market in the future. Chronic diseases are long-term conditions that typically progress slowly and can persist for years or even a lifetime. Factors contributing to these diseases include lifestyle choices, an aging population, genetic predispositions, and environmental influences. AI is increasingly utilized in biopharmaceuticals for managing chronic diseases as it can analyze vast amounts of diverse data, identify patterns, and personalize treatment strategies. For example, in November 2023, the Department of Health and Human Services, a US government agency, reported an 11 percent increase in newly documented chronic hepatitis B cases in 2022 compared to 2021. Consequently, the rising prevalence of chronic diseases is driving growth in the AI biopharmaceuticals market.

Key players in artificial intelligence (AI) in biopharmaceuticals are focused on developing innovative advancements such as target and lead identification suite AI-powered solutions to expedite drug discovery and enable precision medicine, thereby transforming life sciences organizations. These solutions for drug discovery and precision medicine encompass a variety of innovative approaches to developing new drugs and tailoring treatments to individual patients. For example, in May 2023, Google LLC, a US-based provider of cloud computing services, introduced two new AI-powered tools named target and lead identification suites. These tools are designed to assist researchers in predicting and understanding the structure of proteins, a fundamental aspect of drug development. Additionally, the suite facilitates the ingestion, storage, analysis, and sharing of large volumes of genomic data, crucial for precision medicine initiatives. Furthermore, these tools streamline the drug discovery process, reduce costs, and expedite the introduction of new treatments to market. By offering efficient data management, accurate predictions of protein structures, and advanced genomic analysis capabilities, these tools aim to revolutionize drug development processes and enhance patient outcomes.

In February 2023, ZS Associates, a management consulting and technology firm based in the United States, successfully acquired Trials.ai Inc. for an undisclosed sum. This strategic acquisition is geared towards elevating design processes within the pharmaceutical industry by harnessing artificial intelligence (AI). The goal is to optimize operational speed, enhance participant experiences, and accelerate the delivery of pharmaceutical therapies to the market. Trials.ai Inc., headquartered in the US, specializes in revolutionizing clinical trials through the application of artificial intelligence (AI) and machine learning (ML) technologies.

Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrodinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.

North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (ai) in biopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in biopharmaceuticals market consists of revenues earned by entities by services such as drug discovery, personalized medicine analytics, clinical trial optimization, healthcare decision support, and data integration and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in biopharmaceuticals market also includes of sales of decision support System, predictive modeling tools, robotics, and automation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In Biopharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in biopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in biopharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (ai) in biopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Offering: Hardware; Software; Services
• 2) By Deployment: Cloud; On-Premises
• 3) By Technology: Machine Learning; Natural Language Processing; Deep Learning; Other Technologies
• 4) By Application: Business Process And Supply Chain; Drug Discovery; Medical Imaging And Diagnostics; Precision Medicine
• 5) By End-Users: Manufacturers; Contract Research Organizations; Academic And Government Research Institutes
• Subsegments:
• 1) By Hardware: High-Performance Computing Systems; AI-Enabled Laboratory Equipment; Data Storage Solutions
• 2) By Software: Drug Discovery Platforms; Clinical Trial Management Software; Predictive Analytics Tools; Natural Language Processing Solutions
• 3) By Services: Consulting Services; Implementation And Integration Services; Data Management And Analytics Services; Training And Support Services
• Companies Mentioned: Apple Inc.; Google LLC; Microsoft Corporation; Tencent Holdings Limited; Amazon Web Services Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In Biopharmaceuticals Market Characteristics

3. Artificial Intelligence (AI) In Biopharmaceuticals Market Trends And Strategies

4. Artificial Intelligence (AI) In Biopharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Intelligence (AI) In Biopharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI) In Biopharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Biopharmaceuticals Market Segmentation

• 6.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware
• Software
• Services
• 6.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud
• On-Premises
• 6.3. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Machine Learning
• Natural Language Processing
• Deep Learning
• Other Technologies
• 6.4. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Business Process And Supply Chain
• Drug Discovery
• Medical Imaging And Diagnostics
• Precision Medicine
• 6.5. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manufacturers
• Contract Research Organizations
• Academic And Government Research Institutes
• 6.6. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Performance Computing Systems
• AI-Enabled Laboratory Equipment
• Data Storage Solutions
• 6.7. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery Platforms
• Clinical Trial Management Software
• Predictive Analytics Tools
• Natural Language Processing Solutions
• 6.8. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Implementation And Integration Services
• Data Management And Analytics Services
• Training And Support Services

7. Artificial Intelligence (AI) In Biopharmaceuticals Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI) In Biopharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market

• 8.1. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Biopharmaceuticals Market

• 9.1. China Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 9.2. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Biopharmaceuticals Market

• 10.1. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market

• 11.1. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 11.2. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market

• 12.1. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market

• 13.1. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market

• 14.1. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 14.2. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

• 15.1. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 15.2. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Biopharmaceuticals Market

• 16.1. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market

• 17.1. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Biopharmaceuticals Market

• 18.1. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market

• 19.1. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market

• 20.1. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market

• 21.1. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market

• 22.1. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Biopharmaceuticals Market

• 23.1. North America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 23.2. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Biopharmaceuticals Market

• 24.1. USA Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 24.2. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market

• 25.1. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 25.2. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Biopharmaceuticals Market

• 26.1. South America Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 26.2. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market

• 27.1. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market

• 28.1. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 28.2. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market

• 29.1. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market Overview
• 29.2. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI) In Biopharmaceuticals Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Landscape
• 30.2. Artificial Intelligence (AI) In Biopharmaceuticals Market Company Profiles
  • 30.2.1. Apple Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Google LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Tencent Holdings Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Biopharmaceuticals Market Other Major And Innovative Companies

• 31.1. International Business Machines Corporation
• 31.2. Exscientia Limited
• 31.3. NVIDIA Corporation
• 31.4. Amgen Inc.
• 31.5. DeepMind Technologies Limited
• 31.6. Schrodinger Inc.
• 31.7. XtalPi Inc.
• 31.8. ConcertAI Inc.
• 31.9. Insilico Medicine Inc.
• 31.10. Recursion Pharmaceuticals
• 31.11. BenevolentAI
• 31.12. BioXcel Therapeutics
• 31.13. Atomwise Inc.
• 31.14. BioAge Labs Inc.
• 31.15. GNS Healthcare

32. Global Artificial Intelligence (AI) In Biopharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Biopharmaceuticals Market

34. Recent Developments In The Artificial Intelligence (AI) In Biopharmaceuticals Market

35. Artificial Intelligence (AI) In Biopharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI) In Biopharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer